• 1. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Comprehensive Guide to Methyl 2-fluoro-3-hydroxypropanoate (CAS No. 671-30-7): Properties, Applications, and Industry Insights

Methyl 2-fluoro-3-hydroxypropanoate (CAS No. 671-30-7) is a fluorinated ester compound gaining attention in pharmaceutical and specialty chemical industries. This fluoro-hydroxy ester derivative exhibits unique reactivity due to the presence of both fluorine and hydroxyl functional groups, making it a versatile intermediate for synthetic applications. Researchers and manufacturers are increasingly exploring its potential in drug discovery, agrochemicals, and advanced material synthesis.

The molecular structure of Methyl 2-fluoro-3-hydroxypropanoate combines a fluorine substituent at the 2-position with a hydroxyl group at the 3-position, creating distinct electronic and steric effects. This configuration enables selective transformations that are valuable for constructing complex molecular architectures. The compound's CAS 671-30-7 identifier serves as a crucial reference point for regulatory compliance and technical documentation across global markets.

Recent advancements in fluorinated building blocks have spotlighted compounds like Methyl 2-fluoro-3-hydroxypropanoate due to their ability to modulate biological activity and improve metabolic stability in active pharmaceutical ingredients. The pharmaceutical industry particularly values such fluorine-containing intermediates for their potential in developing novel therapeutics with enhanced pharmacokinetic profiles.

Synthetic methodologies for 671-30-7 have evolved significantly, with modern approaches emphasizing atom economy and green chemistry principles. Current research focuses on catalytic asymmetric synthesis routes to access enantiomerically pure forms of this hydroxy-fluoro ester, which are increasingly demanded for chiral drug development. These innovations align with the growing market need for sustainable and efficient production processes.

The physicochemical properties of Methyl 2-fluoro-3-hydroxypropanoate make it particularly suitable for various organic transformations. Its ester functionality allows for straightforward derivatization, while the β-hydroxy-α-fluoro motif serves as a valuable handle for further functionalization. These characteristics explain why CAS 671-30-7 appears frequently in patent literature for innovative synthetic routes.

Analytical characterization of Methyl 2-fluoro-3-hydroxypropanoate typically involves advanced techniques such as NMR spectroscopy (particularly ¹⁹F NMR), mass spectrometry, and chromatographic methods. Quality control protocols for 671-30-7 must account for potential impurities and degradation products, especially when the compound is intended for pharmaceutical applications where purity standards are stringent.

Industrial scale production of fluoro-hydroxy esters like Methyl 2-fluoro-3-hydroxypropanoate requires careful consideration of process safety and environmental impact. Modern manufacturing facilities employ continuous flow chemistry and other innovative technologies to optimize the synthesis of CAS 671-30-7, reducing waste generation and improving energy efficiency in line with green chemistry initiatives.

The commercial availability of Methyl 2-fluoro-3-hydroxypropanoate has expanded in recent years, with specialty chemical suppliers offering both standard and custom synthesis services. Procurement specialists searching for 671-30-7 should evaluate suppliers based on quality certifications, technical support capabilities, and regulatory compliance documentation to ensure material suitability for intended applications.

Emerging applications for fluorinated ester compounds continue to drive interest in Methyl 2-fluoro-3-hydroxypropanoate. Beyond traditional pharmaceutical uses, researchers are exploring its potential in materials science, particularly for modifying polymer properties and creating specialty coatings. The compound's unique combination of fluorine and hydroxyl groups offers interesting possibilities for designing materials with tailored surface characteristics.

Regulatory aspects surrounding CAS 671-30-7 vary by region and application. While not classified as hazardous under standard protocols, proper handling procedures should always be followed when working with Methyl 2-fluoro-3-hydroxypropanoate. Users should consult current safety data sheets and stay informed about evolving regulations concerning fluorinated organic compounds in their specific markets.

Future prospects for Methyl 2-fluoro-3-hydroxypropanoate appear promising as the demand for fluorine-containing fine chemicals continues to grow across multiple industries. Ongoing research into novel synthetic applications and the development of more efficient production methods will likely expand the utility of this versatile chemical intermediate in coming years.

• 100701-49-3(3-Ethoxy-2-fluoro-3-oxopropanoic Acid)
• 2366-56-5(Methyl 2-Fluoropropanoate)
• 1598-96-5(Propanedioicacid, 2-fluoro-, 1,3-dibutyl ester)
• 146805-74-5(Methyl (R)-2-fluoropropionate)
• 685-88-1(Diethyl fluoromalonate)
• 72959-94-5(Ethyl (2R)-2-Fluoropropanoate)
• 344-14-9(Dimethyl fluoromalonate)
• 349-43-9(Ethyl 2-Fluoropropionate)
• 127306-59-6(Ethyl 2-fluoropropionate)
• 99497-39-9(methyl 2,2-difluoro-3-methoxypropanoate)